Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients

BACKGROUND: New biomarkers that replace or are used in conjunction with the current ovarian cancer diagnostic antigen, CA125, are needed for detection of ovarian cancer in the presurgical setting, as well as for detection of disease recurrence. We previously demonstrated the upregulation of leucine-...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Andersen, John D, Boylan, Kristin LM, Jemmerson, Ronald, Geller, Melissa A, Misemer, Benjamin, Harrington, Katherine M, Weivoda, Starchild, Witthuhn, Bruce A, Argenta, Peter, Vogel, Rachel Isaksson, Skubitz, Amy PN
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2010
Предметы:
Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2949730/
https://ncbi.nlm.nih.gov/pubmed/20831812
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1757-2215-3-21
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы